Clinical Trial Update: Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PD-1 antibody sintilimab with or without chemoradiotherapy for locally advanced colorectal cancer (Stage II/III). Active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Not specified
• Sintilimab (sintilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer Stage II, Colorectal Cancer Stage III | Phase 2 | Status: ACTIVE_NOT_RECRUITING